Clinical Trials Results - National Cancer Institute

Skip to content

NCI Home

Cancer Topics

Clinical Trials

Cancer Statistics

Research & Funding

News

About NCI


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -10 of 556 Show results per page	View Search Criteria \| Help With Results

	Title				Phase				Protocol IDs

	PharmacoEconomic Assessment IRESSA® in the Treatment of Non–Small-Cell Lung Cancer (NSCLC)				Phase IV				9461700718 NCT00173524
	Study to Assess Safety/Tolerability/Efficacy of Gefitinib Versus Docetaxel in Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)				Phase IV				D7913C00046 NCT00536107
	Pharmacokinetic Study on the Addition of Aprepitant to Cisplatin - Etoposide Treatment in Lung Cancer Patients				Phase IV				UMCN-AKF 07.02 EudraCTnr 2007-003347-73, NCT00588835
	Concurrent Chemoradiotherapy (CCRT) With Paclitaxel Plus Cisplatin in LA Non-Small-Cell Lung Cancer (NSCLC)				Phase IV				97-02-12 NCT00686322
	A Study of Avastin (Bevacizumab) in Combination With Carboplatin-Based Chemotherapy in Patients With Advanced or Recurrent Non-Squamous Non-Small Cell Lung Cancer.				Phase IV				BO21015 2008-000662-23, NCT00700180
	Paclitaxel Plus Carboplatin With Endostar in Patients of Advanced Non-Small Cell Lung Cancer				Phase IV				XYL014 NCT00708812
	CryoSpray Ablation(tm)in Malignant Airway Disease to Determine Safety, and Tissue Effect in the Lung (ICE the MAD)				Phase IV				08-0106 NCT00748085
	Enbrel Versus Placebo With Radiation Therapy to Combat Fatigue and Cachexia				Phase III, Phase II				001-0015-211 NCT00127387
	Chemotherapy Drug Sensitivity Microculture (MiCK) Assay for Apoptosis				Phase III, Phase II				20050113 NCT00243685
	Effects Of Nadroparin In Patients With Lung, Pancreas Or Prostate Cancer				Phase III, Phase II				FRX106365 NCT00312013


					1 2 3 4 Next >

| | | | | | | |

A Service of the National Cancer Institute